Navigation Links
Aerolase Reports Strong Sales in 2008 for Portable Aesthetic Lasers
Date:1/23/2009

TARRYTOWN, N.Y., Jan. 23 /PRNewswire/ -- Aerolase Corporation, a leading manufacturer of next-generation portable lasers for aesthetic skin treatments, today announced that sales increased dramatically in 2008 over 2007. The company's unique product offerings in the aesthetic laser market helped to more than offset current economic conditions, according to Aerolase executives.

"December 2008 was a record sales month for Aerolase, and 2008 overall represented strong revenue growth with continued gains in Aerolase brand equity," said Dr. Pavel Efremkin, CEO. The company also reported that Q4 2008 revenues increased 119% compared with the corresponding period in 2007, and full-year 2008 revenues increased 76% vs. 2007.

"We are specifically pleased with increased popularity of our leading laser products -- LightPod Neo(TM) and LightPod Era(TM) which perform the full range of popular aesthetic laser skin treatments, including pain-free hair removal, facial skin rejuvenation, skin tightening, spider veins and other vascular lesion removal, scar reduction, treatment of pigmented lesions, acne clearance, tattoo reduction and many others."

In addition, the ASP (average selling price per laser) for LightPod lasers in 2008 increased 14% vs. 2007. "There is a clear and powerful trend of Primary Care Physicians (PCPs) actively adding medical aesthetic treatments to the scope of their regular medical practices," he said. "This trend is based on the increasing demand for rejuvenation from the aging population, who now actively seek these services from their trusted medical providers. The resulting new cash income is highly attractive for these PCPs whose economic circumstances continue to erode, thanks especially to declining reimbursement rates from medical insurers."

Sales to PCPs fueled the growth of Aerolase in 2008, with over half of its sales going into this market segment. The core segment of dermatologists and plastic surgeons is still active for Aerolase, representing about one third of revenues.

"The segment of over 300,000 U.S. PCPs is a huge market opportunity for Aerolase," says Mitchell S. Stern, managing director of SMH Capital Inc., a subsidiary of Sanders Morris Harris Group (Symbol SMHG), which is a financial adviser to Aerolase. "As so many PCPs are just starting medical aesthetic practices, the Nd:YAG 1064nm laser is a natural first choice as it is a must-have laser modality for any aesthetic practitioner -- and the LightPod Neo is clearly the best YAG laser available for this market segment due to its unique combination of high efficacy, exceptional versatility and safety, and a very affordable price. We are very pleased to have Aerolase as our client as it is not easy to find a high growth, high margin company in today's challenging environment," Stern said.

About Aerolase

Aerolase Corporation, Tarrytown, NY, is a world leader in the miniaturization of high-powered medical lasers. This core technology has been commercialized in the fields of medical & aesthetic dermatology as well as capillary blood testing and diabetes management. The company's LightPod(R) lasers cover most aesthetic laser procedures on all skin types as well as many medical treatments. Aerolase lasers are packaged in the innovative LightPod system which utilizes air, rather than water, to continuously cool the internal laser emitter; this patented breakthrough resulted in a laser system that is portable and maintenance-free, also inherently less costly to manufacture and therefore more affordable. For more information, visit www.aerolase.com.

About SMH Capital Inc.

SMH Capital is a registered broker-dealer and a subsidiary of Sanders Morris Harris Group (Nasdaq: SMHG) (member FINRA/SIPC). Sanders Morris Harris Group is a financial services holding company headquartered in Houston that manages approximately $10.3 billion in client assets. The subsidiaries and affiliates of Sanders Morris Harris Group deliver superior wealth advisory, asset management, and capital markets services to individual and institutional investors and middle-market companies. Its operating entities are Dickenson Group, Edelman Financial Center, Salient Partners, Salient Trust Co. LTA, SMH Capital, SMH Capital Advisors, Select Sports Group, and The Rikoon Group. Sanders Morris Harris Group has over 600 employees in 21 states. Additional information is available at http://www.smhgroup.com.


'/>"/>
SOURCE Aerolase Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Aerolase Retains SMH Capital Inc. to Advise on Corporate Expansion
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. QMed, Inc. Reports July Medicare SNP Enrollments
4. Phlo Affiliate Reports Expanded Coverage to Oregon Border
5. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
6. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
7. Carrington Reports Second Quarter 2007 Results
8. Avitar Reports Third Quarter Financial Results for Fiscal 2007
9. Response Genetics Reports Second Quarter 2007 Financial Results
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Transgenomic, Inc. Reports Second Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... ... ... Global Stem Cells Group has announced an inaugural conference and stem cell ... 24-March 6, 2016. The new facility will provide advanced protocols and state-of-the-art techniques in ... CEO Benito Novas will host the event, which will begin with a stem cell ...
(Date:2/12/2016)... 12, 2016  BD (Becton, Dickinson and Company) (NYSE: ... today announced the launch of the BD CLiC™ System ... (AGBT) Meeting. --> ... by providing cost effective NGS library preparation with limited ... fully integrated, next generation sequencing (NGS) library prep instrument, ...
(Date:2/11/2016)... Non-profit Consortium Aims to Generate Genomic Information for ... Discovery --> --> The ... sequence 100,000 individuals. It is intended to initially include populations ... North and East Asian countries. --> ... focus on creating phased reference genomes for all major Asian ...
(Date:2/11/2016)... Germany and GERMANTOWN, Maryland ... ; Frankfurt Prime Standard: QIA) today announced the introduction ... for gene expression profiling, expanding QIAGEN,s portfolio of Sample ... enable researchers to select from over 20,000 human genes ... interactions between genes, cellular phenotypes and disease processes. ...
Breaking Biology Technology:
(Date:2/2/2016)... Feb. 2, 2016 This BCC Research ... market by reviewing the recent advances in high ... drive the field forward. Includes forecast through 2019. ... the challenges and opportunities that exist in the ... solution developers, as well as IT and bioinformatics ...
(Date:2/1/2016)... -- Rising sales of consumer electronics coupled ... gesture control market size through ... electronics coupled with new technological advancements to drive global ... through 2020   --> Rising ... to drive global touchfree intuitive gesture control market ...
(Date:1/25/2016)... Pa. , Jan. 25, 2016   Unisys Corporation ... system at John F. Kennedy (JFK) International Airport, New ... Protection (CBP) identify imposters attempting to enter the ... not belong to them. pilot testing of the ... initially at three terminals at JFK during January 2016. --> ...
Breaking Biology News(10 mins):